Christopher Weber, Ph.D., director, Global Science Initiatives, oversees efforts to advance the scientific agenda of the Alzheimer's Association, the world's largest nonprofit funder of Alzheimer's research. The Association currently has more than $405 million invested in over 1,100 active projects in 56 countries spanning 6 continents. With over 20 years of clinical research experience, Dr. Weber is responsible for communicating the global research landscape of Alzheimer's and dementia, including the breadth and reach of the Association's research programs and the critical need for increased research funding from the public and private sectors.
Dr. Weber directs Association initiatives that convene leaders from across the field to develop, expand and increase the success rate of Alzheimer's diagnostic tools and drugs to treat and prevent the disease. He manages the Alzheimer's Association Research Roundtable, a platform that enables international scientific, industry and government leaders to overcome shared obstacles in Alzheimer's science and drug development. He also oversees the Global Biomarker Standardization Consortium (GBSC), an initiative that unites key researchers and clinicians with industry, regulatory and government leaders to achieve consensus on the best ways to standardize and validate biomarker tests for use in clinical practices worldwide. In addition, Dr. Weber leads the Alzheimer's Association Business Consortium (AABC), which advances innovation in small- and medium-size biotechnology, diagnostics, medical device and contract organizations through pre-competitive collaborations, knowledge sharing and visibility.
He also manages Association efforts as the convener of the Private Partner Scientific Board (PPSB) for ADNI4, the five-year extension of the Alzheimer's Disease Neuroimaging Initiative (ADNI) funded by the NIA with the goal of validating biomarkers for Alzheimer's disease in clinical trials.
Dr. Weber received his doctorate in clinical psychology from the Illinois Institute of Technology. He holds a master's degree in kinesiology from the University of Illinois at Chicago and a bachelor's degree in psychology from the University of Wisconsin-Green Bay. In his personal time, he fundraises for Alzheimer's Association research efforts and has participated in many Ride to End ALZ® events across the United States.